GNF-7 is the first type II inhibitors capable of inhibiting T315I to be described and will serve as a valuable lead to design next generation Bcr-Abl kinase inhibitors.
Molecular Weight:
547.53
Purity:
>98%
CAS Number:
[839706-07-9]
Formula:
C28H24F3N7O2
Target:
Src-bcr-Abl
* VAT and and shipping costs not included. Errors and price changes excepted
